Bill Reh lived with his kidney disease for decades, not needing a transplant until earlier this year. A donor match was found ...

Akebia Therapeutics, Inc. ( NASDAQ:AKBA ) is possibly approaching a major achievement in its business, so we would ...

Immix Biopharma is advancing NXC-201, showing 95% complete/near-complete response rates and superior safety. Learn why IMMX ...

“By 2050, 1.3 billion people are expected to be living with diabetes, and if nearly half don’t know they have a serious and ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

OverviewThe global urology surgical instruments market is projected to witness steady growth at an approximate CAGR of 8% ...

Review: Carol and Manousos hit some real lows in Pluribus Episode 7, “The Gap,” which is a beautifully shot and acted episode ...

Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, today released the following note authored by ...

The man, John Steven Ryals, is accused of passing the other driver in a no-passing zone and shooting at the driver and his daughter.

With ESPN set to release a 30 for 30 about Stuart Scott’s legacy, the broadcaster’s friends reflect on what Scott meant, and ...

Intensity Therapeutics, Inc. ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and development of proprietary cancer therapies using its non-covalent ...

First implantation of two alfapump patients on the same day Continuing strategy of working with Key Opinion Leaders at top tier centers Strong pipeline of additional implanting centers supports ...